Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Integrating differential expression, co-expression and gene network analysis for the identification of common genes associated with tumor angiogenesis deregulation

  • Monterde, Beatriz
  • Rojano, Elena
  • Córdoba-Caballero, José
  • Seoane, Pedro
  • Perkins, James R.
  • Medina, Miguel Ángel
  • Ranea, Juan A.G.
Angiogenesis is essential for tumor growth and cancer metastasis. Identifying the molecular pathways involved in this process is the first step in the rational design of new therapeutic strategies to improve cancer treatment. In recent years, RNA-seq data analysis has helped to determine the genetic and molecular factors associated with different types of cancer. In this work we performed integrative analysis using RNA-seq data from human umbilical vein endothelial cells (HUVEC) and patients with angiogenesis-dependent diseases to find genes that serve as potential candidates to improve the prognosis of tumor angiogenesis deregulation and understand how this process is orchestrated at the genetic and molecular level. We downloaded four RNA-seq datasets (including cellular models of tumor angiogenesis and ischaemic heart disease) from the Sequence Read Archive. Our integrative analysis includes a first step to determine differentially and co-expressed genes. For this, we used the ExpHunter Suite, an R package that performs differential expression, co-expression and functional analysis of RNA-seq data. We used both differentially and co-expressed genes to explore the human gene interaction network and determine which genes were found in the different datasets that may be key for the angiogenesis deregulation. Finally, we performed drug repositioning analysis to find potential targets related to angiogenesis inhibition. We found that that among the transcriptional alterations identified, SEMA3D and IL33 genes are deregulated in all datasets. Microenvironment remodeling, cell cycle, lipid metabolism and vesicular transport are the main molecular pathways affected. In addition to this, interacting genes are involved in intracellular signaling pathways, especially in immune system and semaphorins, respiratory electron transport and fatty acid metabolism. The methodology presented here can be used for finding common transcriptional alterations in other genetically-based diseases., This work was supported by the Spanish Ministry of Science, Innovation and Universities (grant PID2019-105010RB-I00, grant PID2019-108096RB-C21), the Andalusian Government and FEDER (grants UMA18-FEDERJA-102, UMA18-FEDERJA-220, PY20_00257, PY20_00372, RH-0079-2021 and funds from the group PAIDI BIO 267); the Spanish Ministry of Economy and Competitiveness (grant PID2019-108096RB-C21), the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”); and the European Union (HORIZON-HLTH-2022-DISEASE-06, Project ID: 101080580) to JAGR. JRP holds a research grant from the Andalusian Government (Fundacion Progreso y Salud) [PI-0075-2017]. BM is awarded of the Ayudas para la formación del profesorado universitario (FPU18/00755, Ministerio de Universidades)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exploring miRNA-target gene pair detection in disease with coRmiT

  • Córdoba-Caballero, José
  • Perkins, James R.
  • García-Criado, Federico
  • Gallego, Diana
  • Navarro-Sánchez, Alicia
  • Moreno-Estellés, Mireia
  • Garcés, Concepción
  • Bonet, Fernando
  • Romá-Mateo, Carlos
  • Toro, Rocío
  • Pérez, Belén
  • Sanz, Pascual
  • Kohl, Matthias
  • Rojano, Elena
  • Seoane, Pedro
  • Ranea, Juan A. G.
13 páginas, 8 figuras, 1 tabla, A wide range of approaches can be used to detect micro RNA (miRNA)-target gene pairs (mTPs) from expression data, differing in the ways the gene and miRNA expression profiles are calculated, combined and correlated. However, there is no clear consensus on which is the best approach across all datasets. Here, we have implemented multiple strategies and applied them to three distinct rare disease datasets that comprise smallRNA-Seq and RNA-Seq data obtained from the same samples, obtaining mTPs related to the disease pathology. All datasets were preprocessed using a standardized, freely available computational workflow, DEG_workflow. This workflow includes coRmiT, a method to compare multiple strategies for mTP detection. We used it to investigate the overlap of the detected mTPs with predicted and validated mTPs from 11 different databases. Results show that there is no clear best strategy for mTP detection applicable to all situations. We therefore propose the integration of the results of the different strategies by selecting the one with the highest odds ratio for each miRNA, as the optimal way to integrate the results. We applied this selection-integration method to the datasets and showed it to be robust to changes in the predicted and validated mTP databases. Our findings have important implications for miRNA analysis. coRmiT is implemented as part of the ExpHunterSuite Bioconductor package available from https://bioconductor.org/packages/ExpHunterSuite., This work is supported by funds from Spanish Ministry of Economy and Competitiveness [PID2019-108096RB-C21 and PID2022-140047OB-C21]; the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”); and the European Union through the project EURAS, Grant Agreement No: 101080580, Horizon Europe. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency.Neither the European Union nor the granting authority can be held responsible for them. (HORIZONHLTH-2022-DISEASE-06); Biomedicine research projects [PI-00752017 and PEER-0019-2020](FoundationProgreso y Salud).CIBERER is an initiative from the Institute of Health Carlos III., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A text mining and ontology-based approach using phenotypes to obtain relevant literature for rare diseases

  • Pérez-García, Jesús
  • García-Criado, Federico
  • Pazos, Florencio
  • Chagoyen, Mónica
  • Rojano, Elena
  • Seoane, Pedro
  • Ranea, Juan A. G.
Diagnosing rare diseases remains a major challenge due to limited clinical knowledge and the frequent absence of diagnostic criteria. We present a digital framework that leverages large language models and biomedical text embeddings to bridge this gap. By mapping Human Phenotype Ontology terms to a shared vector space with millions of PubMed abstracts and full-text articles, our method enables phenotype-driven semantic search and ranks literature relevant to patient symptoms, even without explicit disease mentions. Validated on OMIM-derived benchmarks and applied to RASopathies, including NF1, Noonan, and Costello syndromes, our approach retrieved expected findings, supporting differential diagnosis and research. The framework is implemented in an open-source Python package, py-semtools, and it can be integrated into clinical decision support systems or adapted to other ontologies and corpora. This work demonstrates how AI-driven informatics can enhance rare disease diagnosis and exemplifies the role of digital tools in transforming precision medicine and healthcare delivery., This work is supported by funds from Spanish Ministry of Economy and Competitiveness [PID2019-108096RB-C21 and PID2022-140047OB-C21, PID2022-140047OB-C22]; the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”); and the European Union through the project EURAS (Horizon Europe HORIZON-HLTH-2022-DISEASE-06, Project ID: 101080580) to J.A.G.R. The EURAS project receives funding from the European Union’s Horizon Europe Research and Innovation Programme under grant agreement no. 101080580 (HORIZON-HLTH-2022-DISEASE-06). Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. Biomedicine research projects [PI-0075-2017 and PEER-0019-2020] are funded by Fundación Progreso y Salud. E.R. hold a research grant from the Instituto de Investigación Biomédica de Málaga (IBIMA-Plataforma BIONAND) [PI RARE 24-03]. J.P.G. is a predoctoral researcher from “ayudas para contratos predoctorales para la formación de doctores” (PRE2022/000510) supported by the Ministerio de Ciencia, Innovación y Universidades. F.G.C. is a predoctoral researcher from “ayudas para contratos predoctorales para la Formación del Profesorado Universitario” (FPU21/01449) supported by the Ministerio de Ciencia, Innovación y Universidades. The “CIBER de Enfermedades Raras” is an initiative from the ISCIII (Spain). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors thank the Supercomputing and Bioinnovation Center (SCBI) of the University of Málaga for their provision of computational resources and technical support (http://www.scbi.uma.es/site). We thank to Junta de Andalucía its support to PAIDI BIO-267 group., Peer reviewed